Pilar Llamas-Sillero

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Case Report: Central nervous system relapse treated with elranatamab after prior BCMA and GPRC5D directed therapies in relapsed/refractory multiple myeloma.

Case Report: Central nervous system relapse treated with elranatamab after prior BCMA and GPRC5D directed therapies in relapsed/refractory multiple myeloma.

Journal: Frontiers in oncology
Published: May 24, 2026

APTTO: a clot waveform analysis-based algorithm for diagnostic triage of prolonged activated partial thromboplastin time.

APTTO: a clot waveform analysis-based algorithm for diagnostic triage of prolonged activated partial thromboplastin time.

Journal: Thrombosis research
Published: April 13, 2026

What factors influence patient participation in an artificial intelligence-based initiative to optimise referrals from primary to specialist haematology care? A multicentre retrospective observational study in four Spanish hospitals.

What factors influence patient participation in an artificial intelligence-based initiative to optimise referrals from primary to specialist haematology care? A multicentre retrospective observational study in four Spanish hospitals.

Journal: BMJ open
Published: March 24, 2026

Hemi-Orolingual Angioedema in a Patient With VEXAS Syndrome.

Hemi-Orolingual Angioedema in a Patient With VEXAS Syndrome.

Journal: EJHaem
Published: September 11, 2025

A novel GATA1 variant linking germline and somatic myelodysplastic syndrome in two patients.

A novel GATA1 variant linking germline and somatic myelodysplastic syndrome in two patients.

Journal: Haematologica
Published: September 05, 2025

CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma.

CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma.

Journal: Frontiers in immunology
Published: August 27, 2025

Multicenter Interlaboratory Study of Thrombin Generation Assay in Healthy Adults Using the ST Genesia Analyzer With the STG-ThromboScreen Reagent (With and Without Thrombomodulin).

Multicenter Interlaboratory Study of Thrombin Generation Assay in Healthy Adults Using the ST Genesia Analyzer With the STG-ThromboScreen Reagent (With and Without Thrombomodulin).

Journal: International journal of laboratory hematology
Published: August 21, 2025

Development of PREVEMM: A Venous Thromboembolism Risk Score for Newly Diagnosed Multiple Myeloma Patients.

Development of PREVEMM: A Venous Thromboembolism Risk Score for Newly Diagnosed Multiple Myeloma Patients.

Journal: Clinical lymphoma, myeloma & leukemia
Published: July 14, 2025

How well do different chatbots respond to multiple myeloma treatment guidelines?

How well do different chatbots respond to multiple myeloma treatment guidelines?

Journal: Leukemia
Published: March 16, 2025

Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy.

Significant attenuation of fully automated thrombin generation in newly diagnosed multiple myeloma patients after induction therapy.

Journal: Journal of thrombosis and thrombolysis
Published: February 13, 2025

Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen.

Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen.

Journal: Journal for immunotherapy of cancer
Published: November 25, 2024

Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome.

Flow Cytometry Analysis of Mesenchymal Stem Cells: A Predictive Biomarker for Leukemia Transformation in Myelodysplastic Syndrome.

Journal: EJHaem
Published: October 23, 2024
Showing 1-12 of 32

Last Updated: 09/26/2026